跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,611 条关于
“CMS Holdings”
全部
5,611
临床试验
3,103
药物
842
机构
200
资讯
1,466
8个月前
Alpha Cognition Launches Real-World Study for ZUNVEYL as Alzheimer's Drug Gains Commercial Traction
去年
Ruxolitinib Cream Prescriptions for Vitiligo Issued in Greater Bay Area, China; NDA Accepted by NMPA
去年
Lumeblue® First Prescriptions Issued in China for Colorectal Lesion Visualization
19天前
Leios Therapeutics Licenses 10XB-101 to China Medical System for Focal Fat Reduction
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
12个月前
CMS Secures Exclusive Rights to Two Breakthrough Antibody Therapies for Tetanus and Rabies Prevention
上个月
MMJ Challenges CMS Over Medicare Program Funding Non-FDA-Approved Cannabinoid Products While Demanding FDA Approval Pathway
去年
China Medical System Gains Exclusive Rights to Gout Drug ABP-671
4个月前
CMS Secures Exclusive Rights to Market Advanced Intravenous Iron Therapies in China Through 15-Year Partnership with Pharmacosmos
去年
CMS Proposes New Payment Structure for Skin Substitutes, Regenerative Medicine Companies Welcome Reform
第 1 页,共 147 页
上一页
下一页